Endocrine treatment of breast cancer is an important means of treatment, mainly through drug interventions to regulate the hormonal levels of women, thereby disrupting or inhibiting breast cancer cell-to-female use for the purpose of breast cancer treatment. Here is a detailed analysis of the endocrinology of breast cancer. I. Types of drugs for endocrine treatment
estrogen receptor regulaters: e.g., mosifine, Icemetan, etc. Such drugs can selectively combine estrogen receptors with breast cancer cells, rendering them undependent on estrogens, thereby inhibiting breast cancer cell growth and diffusion.
Aromatic enzyme inhibitors: e.g., Atieru. Such drugs inhibit the activity of aromatic enzymes in the body and reduce the synthesis of estrogens in the body, thereby inhibiting breast cancer cell growth and preventing their spread.
estrogen receptor downwards: e.g. Foma acid fluent. Such drugs can have an effect on estrogen receptors, bring down their numbers and reduce their expression levels, thus reducing breast cancer cell dependence on estrogen.
II. People with endocrine treatment
Endocrine treatment is applied mainly to estrogen-positive patients with breast cancer. This group of patients has some dependence on estrogen, so it can be effectively controlled by regulating estrogen levels.
III. Effectiveness of endocrine treatment
Endocrine treatments usually have better treatment outcomes, especially among early breast cancer patients. It can prolong the patient ‘ s life and improve his/her quality of life. At the same time, endocrine treatment has relatively low side effects, such as tidal heat, menstruation and osteoporosis, which are much lighter than chemotherapy and decomposition.
IV. Attention to endocrine treatment
Individualized treatment: individualized endocrine treatment programmes are adapted to the specific situation of the patient to ensure that the treatment is effective and that the side effects are reduced.
Long-term treatment: Endocrine treatment usually takes place on a long-term basis and patients need to use their medication on time and be reviewed regularly.
Monitoring side effects: During treatment, patients are closely monitored and reported to doctors in a timely manner. The doctor adjusts the treatment to the patient ‘ s specific condition or takes the necessary measures to mitigate the side effects.
Nutritional support: The patient needs to maintain a nutritional balance in the treatment and avoid eating foods that could affect hormone levels, such as soybean products.
Limitations of endocrine treatment
Endocrine treatment for breast cancer has had significant results but also limitations. For example, the effect of urogen treatment is not known for negative estrogen receptors in breast cancer patients. In addition, long-term endocrine treatment may also result in drug resistance among some patients, reducing the effectiveness of treatment.
On the whole, endocrine treatment of breast cancer is a safe and effective treatment that is more appropriate for breast cancer patients who are positive for estrogen receptors. In the course of treatment, patients closely monitor the emergence of side effects and take their medications and review them regularly.
